BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schieda N, Maralani PJ, Hurrell C, Tsampalieros AK, Hiremath S. Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 2019;70:226-32. [DOI: 10.1016/j.carj.2019.04.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen ET, Hague C, Manos D, Memauri B, Souza C, Taylor J, Dennie C. Canadian Society of Thoracic Radiology/Canadian Association of Radiologists Best Practice Guidance for Investigation of Acute Pulmonary Embolism, Part 1: Acquisition and Safety Considerations. Can Assoc Radiol J 2021;:8465371211000737. [PMID: 33781098 DOI: 10.1177/08465371211000737] [Reference Citation Analysis]
2 Lunyera J, Mohottige D, Alexopoulos AS, Campbell H, Cameron CB, Sagalla N, Amrhein TJ, Crowley MJ, Dietch JR, Gordon AM, Kosinski AS, Cantrell S, Williams JW Jr, Gierisch JM, Ear B, Goldstein KM. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. Ann Intern Med 2020;173:110-9. [PMID: 32568573 DOI: 10.7326/M20-0299] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review. Am J Kidney Dis 2021;77:517-28. [PMID: 32861792 DOI: 10.1053/j.ajkd.2020.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abu-alfa AK. Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change. American Journal of Kidney Diseases 2020;76:436-9. [DOI: 10.1053/j.ajkd.2020.03.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Biersmith MA, Tong MS, Guha A, Simonetti OP, Addison D. Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies. J Am Heart Assoc 2020;9:e013755. [PMID: 31960741 DOI: 10.1161/JAHA.119.013755] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
6 Lersy F, Boulouis G, Clément O, Desal H, Anxionnat R, Berge J, Boutet C, Kazémi A, Pyatigorskaya N, Lecler A, Saleme S, Edjlali-Goujon M, Kerleroux B, Ben Salem D, Kremer S, Cotton F. Consensus Guidelines of the French Society of Neuroradiology (SFNR) on the use of Gadolinium-Based Contrast agents (GBCAs) and related MRI protocols in Neuroradiology. J Neuroradiol 2020;47:441-9. [PMID: 32565280 DOI: 10.1016/j.neurad.2020.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
7 Chen CW, Tseng YH, Wong MY, Wu CM, Lin BS, Huang YK. Stasis Leg Ulcers: Venous System Revises by Triggered Angiography Non-Contrast-Enhanced Sequence Magnetic Resonance Imaging. Diagnostics (Basel) 2020;10:E707. [PMID: 32957628 DOI: 10.3390/diagnostics10090707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Gauthier ID, Macleod CA, Sathiadoss P, Mcgrath TA, Nair V, Schieda N. Risk of nephrogenic systemic fibrosis (NSF) in oncology patients receiving gadoxetic acid and updated risk of estimate of NSF in patients receiving gadoxetic acid with moderate and severe renal impairment. Abdom Radiol. [DOI: 10.1007/s00261-021-03367-3] [Reference Citation Analysis]
9 Schieda N, van der Pol CB, Walker D, Tsampalieros AK, Maralani PJ, Woo S, Davenport MS. Adverse Events to the Gadolinium-based Contrast Agent Gadoxetic Acid: Systematic Review and Meta-Analysis. Radiology 2020;297:565-72. [DOI: 10.1148/radiol.2020200073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
10 Costelloe CM, Amini B, Madewell JE. Risks and Benefits of Gadolinium-Based Contrast-Enhanced MRI. Seminars in Ultrasound, CT and MRI 2020;41:170-82. [DOI: 10.1053/j.sult.2019.12.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kalantari K, Swaminathan S. Use of Gadolinium in Individuals with Reduced Kidney Function. Clin J Am Soc Nephrol 2021;16:304-6. [PMID: 33431379 DOI: 10.2215/CJN.13950820] [Reference Citation Analysis]
12 Ian Paterson D, White JA, Butler CR, Connelly KA, Guerra PG, Hill MD, James MT, Kirpalani A, Lydell CP, Roifman I, Sarak B, Sterns LD, Verma A, Wan D, Crean AM, Grosse-Wortmann L, Hanneman K, Leipsic J, Manlucu J, Nguyen ET, Sandhu RK, Villemaire C, Wald RM, Windram J; Primary Panel., Secondary Panel. 2021 Update on Safety of Magnetic Resonance Imaging: Joint Statement From Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society. Can J Cardiol 2021;37:835-47. [PMID: 34154798 DOI: 10.1016/j.cjca.2021.02.012] [Reference Citation Analysis]
13 Walker D, McGrath TA, Glikstein R, Chakraborty S, Blanchette C, Schieda N. Empiric Switching of Gadolinium-Based Contrast Agents in Patients With History of Previous Immediate Hypersensitivity Reaction to GBCA: A Prospective Single-Center, Single-Arm Efficacy Trial. Invest Radiol 2021;56:369-73. [PMID: 33337738 DOI: 10.1097/RLI.0000000000000750] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Costelloe CM, Amini B, Madewell JE. WITHDRAWN: Risks and Benefits of Gadolinium-Based Contrast Enhanced MRI. Semin Ultrasound CT MR 2020;41:260-74. [PMID: 32446435 DOI: 10.1053/j.sult.2020.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology 2021;298:28-35. [PMID: 33170103 DOI: 10.1148/radiol.2020202903] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
16 Benzon HT, Maus TP, Kang HR, Provenzano DA, Bhatia A, Diehn F, Nelson A, McCormick ZL, Liu BP, de Andres Ares J, Anitescu M, Blackham K, Bhaskar A, Brill S, Collins J, Gulve A, Hurley RW, Jeon YH, Moon JY, Rauck RL, Rodes M, Lee RK, Shah V, Shanthanna H, van Zundert J, Huntoon M, Rathmell JP, Borges MS, Cohen SP, Greenberger PA. The Use of Contrast Agents in Interventional Pain Procedures: A Multispecialty and Multisociety Practice Advisory on Nephrogenic Systemic Fibrosis, Gadolinium Deposition in the Brain, Encephalopathy After Unintentional Intrathecal Gadolinium Injection, and Hypersensitivity Reactions. Anesth Analg 2021;133:535-52. [PMID: 33755647 DOI: 10.1213/ANE.0000000000005443] [Reference Citation Analysis]
17 Krishna S, Schieda N, Pedrosa I, Hindman N, Baroni RH, Silverman SG, Davenport MS. Update on MRI of Cystic Renal Masses Including Bosniak Version 2019. J Magn Reson Imaging 2021;54:341-56. [PMID: 33009722 DOI: 10.1002/jmri.27364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Pasumarthi S, Tamir JI, Christensen S, Zaharchuk G, Zhang T, Gong E. A generic deep learning model for reduced gadolinium dose in contrast-enhanced brain MRI. Magn Reson Med 2021;86:1687-700. [PMID: 33914965 DOI: 10.1002/mrm.28808] [Reference Citation Analysis]
19 van der Molen AJ. Gadolinium Deposition in the Brain and Body. Journal of the Belgian Society of Radiology 2019;103:71. [DOI: 10.5334/jbsr.1945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Freitas PS, Janicas C, Veiga J, Matos AP, Herédia V, Ramalho M. Imaging evaluation of the liver in oncology patients: A comparison of techniques. World J Hepatol 2021; 13(12): 1936-1955 [DOI: 10.4254/wjh.v13.i12.1936] [Reference Citation Analysis]
21 Chen CW, Tseng YH, Fang YF, Wong MY, Lin YH, Huang YK. Superficial Venous Reflux Intervention Guided by Triggered Angiography Non-Contrast-Enhanced Sequence Magnetic Resonance Imaging: Different QFlow Pattern from Health Controls. J Pers Med 2021;11:751. [PMID: 34442395 DOI: 10.3390/jpm11080751] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Chen CW, Tseng YH, Lin CC, Kao CC, Wong MY, Lin BS, Huang YK. Novel Diagnostic Options without Contrast Media or Radiation: Triggered Angiography Non-Contrast-Enhanced Sequence Magnetic Resonance Imaging in Treating Different Leg Venous Diseases. Diagnostics (Basel) 2020;10:E355. [PMID: 32485855 DOI: 10.3390/diagnostics10060355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
23 Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Kidney Med 2021;3:142-50. [PMID: 33604544 DOI: 10.1016/j.xkme.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
24 de Laforcade L, Bobot M, Bellin MF, Clément O, Grangé S, Grenier N, Wynckel A, Guerrot D. Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines. Diagn Interv Imaging 2021;102:131-9. [PMID: 33531265 DOI: 10.1016/j.diii.2021.01.007] [Reference Citation Analysis]
25 de Laforcade L, Bobot M, Bellin MF, Clément O, Grangé S, Grenier N, Wynckel A, Guerrot D; Comité Scientifique du Club des Jeunes Néphrologues., French Intensive care Renal Network,., Commission Néphrologie Clinique de la Société Francophone de Néphrologie, Dialyse et Transplantation. [ESUR recommendations on the use of contrast media: Practice survey, review and commentary by CJN, FIRN and SFNDT]. Nephrol Ther 2021;17:80-91. [PMID: 33551369 DOI: 10.1016/j.nephro.2020.10.011] [Reference Citation Analysis]
26 Chen CW, Fang YF, Tseng YH, Wong MY, Lin YH, Hsu YC, Lin BS, Huang YK. A Novel Tool for a Challenging Disease: Stasis Leg Ulcers Assessed Using QFlow in Triggered Angiography Noncontrast Enhanced Magnetic Resonance Imaging. J Pers Med 2021;11:857. [PMID: 34575634 DOI: 10.3390/jpm11090857] [Reference Citation Analysis]
27 Windpessl M, Prischl FC, Prenner A, Vychytil A. Managing Hospitalized Peritoneal Dialysis Patients: Ten Practical Points for Non-Nephrologists. Am J Med 2021;134:833-9. [PMID: 33737056 DOI: 10.1016/j.amjmed.2021.02.007] [Reference Citation Analysis]
28 Tseng YH, Chen CW, Wong MY, Yang TY, Lin BS, Ting H, Huang YK. Discriminating Reflux from Non-Reflux Diseases of Superficial Veins in Legs by Novel Non-Contrast MR with QFlow Technique. J Pers Med 2021;11:242. [PMID: 33810500 DOI: 10.3390/jpm11040242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
29 Alabousi M, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In Training. Radiology 2021;300:279-84. [PMID: 34060939 DOI: 10.1148/radiol.2021210044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Chen CW, Tseng YH, Wong MY, Lin YH, Yang TY, Hsu YC, Lin BS, Huang YK. Using Non-Contrast MRA to Discriminate between Obstructive and Nonobstructive Venous Diseases of the Legs. Diagnostics (Basel) 2021;11:1392. [PMID: 34441326 DOI: 10.3390/diagnostics11081392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]